|
|
Office Locations:
|
1400 Main Street, Floor 1
Waltham, MA 02451
Phone: 617-340-2538
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need. The firm maintains a balanced two-pronged approach, between clinical stage companies with high commercial potential and early-stage transformative technologies prime for future M&A. The firm makes direct equity investments across all stages of clinical development in Therapeutic Areas such as: Rare diseases, Oncology, Neurology / CNS, and Immunology.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
